+987.9%
MRNA vs XME
+5.2%
+982.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | XME | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -1.0% | +14.1% | +14.2% |
| 7D | +20.6% | -5.5% | +26.1% | +28.0% |
| 30D | +27.1% | -11.1% | +38.3% | +44.8% |
| 3M | +353.4% | -11.1% | +364.5% | +440.2% |
| 6M | +446.3% | -18.0% | +464.3% | +572.5% |
| YTD | +776.2% | -7.4% | +783.5% | +843.9% |
| 1Y | +987.9% | +6.7% | +981.2% | +904.8% |
| All | +987.9% | +5.2% | +982.7% | +904.8% |
Cumulative growth
Daily Returns
Daily percentage return beside XME.
Daily Out/Under-Performance
Portfolio return minus XME return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × XME return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded XME wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling